Echerd Margaret 4
4 · Vaxart, Inc. · Filed Dec 1, 2021
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
Echerd Margaret
VP, Corporate Controller, PAO
Transactions
- Exercise/Conversion
Common Stock
2021-11-30$0.77/sh+2,936$2,261→ 3,602 total - Sale
Common Stock
2021-11-30$8.00/sh−3,602$28,816→ 0 total - Exercise/Conversion
Common Stock
2021-11-30$5.17/sh+666$3,443→ 666 total - Exercise/Conversion
Stock Option (right to buy)
2021-11-30−666→ 1,667 totalExercise: $5.17Exp: 2028-05-24→ Common stock (666 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-11-30−2,936→ 26,416 totalExercise: $0.77Exp: 2029-06-11→ Common stock (2,936 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
- [F2]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of April 9, 2018, and the remaining shares in 36 equal monthly installments thereafter.
- [F3]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.